Tiotropium Showing Promise in Pediatric Asthma
Medscape AUSTIN — In children with poorly controlled asthma, once-daily tiotropium delivered with the Respimat inhaler improves lung function when added to inhaled corticosteroids, with no apparent change in adverse effects, new research has shown. The drug … |
View full post on asthma – Google News